- Shinkowa Pharmaceutical Co., Ltd.
- February, 2019
- 20,000,000 JPY
- Main Office
- 2-30-11, Shinkawa, Chuo-ku, Tokyo, Japan, 104-0033
- Megumi Tanaka
- Business overview
・Development, manufacture and sales of nutraceuticals (health food and cosmetics)
・Manufacture and sales of medicines
・Management consulting business
・Import, export and sales of domestic and foreign goods
- Main customers
- Overseas factories, domestic sales companies, distributors, platforms and others.
- Subsidiary companies
- Shinkowa Pharma USA.Inc、Hakushindo Pharmaceutical Co., Ltd.
In-house research laboratoryFacility
- Life Science Lab
Nihonbashi Honcho, Chuo-ku, Tokyo, Japan 103-0023
(Nihonbashi Life Science Building)
- Access to the
- 3 minutes' walk from Exit A6 at Mitsukoshi-mae Station on the Tokyo Metro Ginza Line- Hanzomon Line/ 2 minutes' walk from Exit 5 on the JR Sobu Line Rapid Shin-Nihonbashi Station
- May 2016
Founded as Orient Biomedic Co., Ltd.
- April 2019
Research of NMN and all businesses were succeeded from Shinkowa Pharmaceutical Co., Ltd. and the company name was changed.
- July 2019
In-house NMN research facility “Life Science Lab” opened in 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo (Nihonbashi Life Science Building B1F).